White matter hyperintensities are seen only inGRNmutation carriers in the GENFI cohort.
View / Open Files
Authors
Sudre, Carole H
Bocchetta, Martina
Cash, David
Thomas, David L
Woollacott, Ione
Dick, Katrina M
van Swieten, John
Borroni, Barbara
Galimberti, Daniela
Masellis, Mario
Tartaglia, Maria Carmela
Graff, Caroline
Tagliavini, Fabrizio
Frisoni, Giovanni
Laforce, Robert
Finger, Elizabeth
de Mendonça, Alexandre
Sorbi, Sandro
Ourselin, Sébastien
Cardoso, M Jorge
Rohrer, Jonathan D
Genetic FTD Initiative, GENFI,
Journal Title
Neuroimage Clin
ISSN
2213-1582
Volume
15
Pages
171-180
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Sudre, C. H., Bocchetta, M., Cash, D., Thomas, D. L., Woollacott, I., Dick, K. M., van Swieten, J., et al. (2017). White matter hyperintensities are seen only inGRNmutation carriers in the GENFI cohort.. Neuroimage Clin, 15 171-180. https://doi.org/10.1016/j.nicl.2017.04.015
Abstract
Genetic frontotemporal dementia is most commonly caused by mutations in the progranulin(GRN), microtubule-associated protein tau (MAPT)and chromosome 9 open reading frame 72(C9orf72) genes. Previous small studies have reported the presence of cerebral white matter hyperintensities (WMH) in genetic FTD but this has not been systematically studied across the different mutations. In this study WMH were assessed in 180 participants from the Genetic FTD Initiative (GENFI) with 3D T1- and T2-weighed magnetic resonance images: 43 symptomatic (7GRN, 13MAPTand 23C9orf72), 61 presymptomatic mutation carriers (25GRN, 8MAPTand 28C9orf72) and 76 mutation negative non-carrier family members. An automatic detection and quantification algorithm was developed for determining load, location and appearance of WMH. Significant differences were seen only in the symptomaticGRNgroup compared with the other groups with no differences in theMAPTorC9orf72groups: increased global load of WMH was seen, with WMH located in the frontal and occipital lobes more so than the parietal lobes, and nearer to the ventricles rather than juxtacortical. Although no differences were seen in the presymptomatic group as a whole, in theGRNcohort only there was an association of increased WMH volume with expected years from symptom onset. The appearance of the WMH was also different in theGRNgroup compared with the other groups, with the lesions in theGRNgroup being more similar to each other. The presence of WMH in those with progranulin deficiency may be related to the known role of progranulin in neuroinflammation, although other roles are also proposed including an effect on blood-brain barrier permeability and the cerebral vasculature. Future studies will be useful to investigate the longitudinal evolution of WMH and their potential use as a biomarker as well as post-mortem studies investigating the histopathological nature of the lesions.
Keywords
CI, Confidence interval, FTD, Frontotemporal dementia, IQR, Inter Quartile Range, PS, Presymptomatic, S, Symptomatic, TIV, Total Intracranial volume, WMH, White matter hyperintensity, Adult, Aged, C9orf72 Protein, Cohort Studies, Female, Frontotemporal Dementia, Humans, Intercellular Signaling Peptides and Proteins, Magnetic Resonance Imaging, Male, Middle Aged, White Matter, tau Proteins
Sponsorship
WELLCOME TRUST (103838/Z/14/Z)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
MEDICAL RESEARCH COUNCIL (MR/J009482/1)
Medical Research Council (MC_U105597119)
Identifiers
External DOI: https://doi.org/10.1016/j.nicl.2017.04.015
This record's URL: https://www.repository.cam.ac.uk/handle/1810/269625
Recommended or similar items
The following licence files are associated with this item: